Literature DB >> 21104295

Guillain-Barré syndrome and glioblastoma.

Isaac Melguizo1, Mark Gilbert, Sudhakar Tummala.   

Abstract

Guillain-Barré syndrome (GBS) is defined as an acute demyelinating peripheral neuropathy. We describe a case of GBS in a patient with glioblastoma undergoing chemotherapy treatment. A 57 year old woman diagnosed with glioblastoma developed a subacute progressive history of bilateral symmetric numbness of her fingers and toes, belt-type neuropathic pain, a left facial droop and upper and lower extremity muscle weakness. There was no evidence of a tumor mass or leptomeningeal disease in the spine. Electrophysiological studies confirmed the diagnosis. Although rare, GBS should be considered in primary brain tumor patients with generalized acute-subacute progressive weakness that is inconsistent with the location of their tumor, particularly if they are also on chemotherapy contributing to their immunosuppressive state.

Entities:  

Mesh:

Year:  2010        PMID: 21104295     DOI: 10.1007/s11060-010-0471-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  8 in total

1.  Glioblastoma multiforme and ascending weakness.

Authors:  L J Cooke; William Morrish; W J Becker
Journal:  Can J Neurol Sci       Date:  2002-11       Impact factor: 2.104

2.  Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy.

Authors:  J W Albers; P D Donofrio; T K McGonagle
Journal:  Muscle Nerve       Date:  1985 Jul-Aug       Impact factor: 3.217

3.  Guillain-Barré syndrome in a patient with metastatic colon cancer receiving oxaliplatin-based chemotherapy.

Authors:  C Christodoulou; D Anastasopoulos; A Visvikis; S Mellou; I Detsi; G Tsiakalos; A Pateli; G Klouvas; A Papadimitriou; D V Skarlos
Journal:  Anticancer Drugs       Date:  2004-11       Impact factor: 2.248

4.  [Guillain-Barre syndrome following resection of glioblastoma multiforme].

Authors:  I Puertas-Muñoz; P Miranda-Lloret; A Lagares; A Ramos-González
Journal:  Rev Neurol       Date:  2004 Dec 16-31       Impact factor: 0.870

5.  Guillain-Barré syndrome after transplantation.

Authors:  Lin Zhang; Sheila Arrington; Yi-Kong Keung
Journal:  Leuk Lymphoma       Date:  2008-02

Review 6.  Guillain-Barré syndrome: epidemiology, pathophysiology and management.

Authors:  Satoshi Kuwabara
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Guillain-Barré syndrome and influenza virus infection.

Authors:  Valérie Sivadon-Tardy; David Orlikowski; Raphaël Porcher; Tarek Sharshar; Marie-Christine Durand; Vincent Enouf; Flore Rozenberg; Christiane Caudie; Djillali Annane; Sylvie van der Werf; Pierre Lebon; Jean-Claude Raphaël; Jean-Louis Gaillard; Elyanne Gault
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

8.  Immunoglobulin IgG Fc-receptor polymorphisms and HLA class II molecules in Guillain-Barré syndrome.

Authors:  S Sinha; K N Prasad; D Jain; K K Nyati; S Pradhan; S Agrawal
Journal:  Acta Neurol Scand       Date:  2010-01-25       Impact factor: 3.209

  8 in total
  2 in total

Review 1.  Myasthenia gravis after glioblastoma resection: paraneoplastic syndrome or coincidence? A unique case report and review of the literature.

Authors:  R J Slegers; T A M Bouwens van der Vlis; L Ackermans; A Hoeben; A A Postma; I Compter; J G J Hoeijmakers; J Beckervordersandforth; M P G Broen; O E M G Schijns
Journal:  Acta Neurochir (Wien)       Date:  2021-10-29       Impact factor: 2.216

2.  Is peripheral paraneoplastic neurological syndrome possible in primary brain tumors?

Authors:  Magdalena Koszewicz; Slawomir Michalak; Malgorzata Bilinska; Slawomir Budrewicz; Mikolaj Zaborowski; Krzysztof Slotwinski; Ryszard Podemski; Maria Ejma
Journal:  Brain Behav       Date:  2016-04-27       Impact factor: 2.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.